tiprankstipranks
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
US Market
CPIX
Cumberland Pharmaceuticals
RESEARCH TOOLSreports

Cumberland Pharmaceuticals (CPIX) Ratios

228 Followers

Cumberland Pharmaceuticals Ratios

CPIX's free cash flow for Q4 2025 was $0.84. For the 2025 fiscal year, CPIX's free cash flow was decreased by $ and operating cash flow was $-0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.01 1.01 1.15 1.28 1.60
Quick Ratio
 0.84 0.84 1.03 1.11 1.26
Cash Ratio
 0.31 0.31 0.57 0.65 0.69
Solvency Ratio
 0.04 0.05 >-0.01 0.03 >-0.01
Operating Cash Flow Ratio
 0.13 0.13 -0.02 0.22 0.30
Short-Term Operating Cash Flow Coverage
 10.54 10.54 -0.12 0.00 0.00
Net Current Asset Value
$ -15.22M$ -15.22M$ -16.59M$ -16.80M$ -11.08M
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.27 0.23 0.23
Debt-to-Equity Ratio
 0.41 0.41 0.90 0.62 0.58
Debt-to-Capital Ratio
 0.29 0.29 0.47 0.38 0.37
Long-Term Debt-to-Capital Ratio
 0.17 0.17 0.31 0.30 0.31
Financial Leverage Ratio
 3.09 3.09 3.31 2.76 2.56
Debt Service Coverage Ratio
 2.74 2.55 0.04 3.65 0.45
Interest Coverage Ratio
 -5.63 -5.63 -10.62 -14.31 -9.74
Debt to Market Cap
 0.12 0.10 0.46 0.50 0.49
Interest Debt Per Share
 0.71 0.71 1.51 1.34 1.48
Net Debt to EBITDA
 -0.47 -0.51 14.30 0.04 3.61
Profitability Margins
Gross Profit Margin
85.02%85.02%82.61%84.66%78.29%
EBIT Margin
-5.20%-6.27%-15.48%-14.20%-11.89%
EBITDA Margin
6.03%5.60%0.48%6.28%0.79%
Operating Profit Margin
-6.27%-6.27%-16.99%-24.16%-13.58%
Pretax Profit Margin
-6.34%-6.34%-17.08%-15.89%-13.29%
Net Profit Margin
-6.37%-6.37%-17.11%-15.88%-13.26%
Continuous Operations Profit Margin
-6.43%-6.43%-17.02%-16.01%-13.45%
Net Income Per EBT
100.41%100.41%100.21%99.91%99.80%
EBT Per EBIT
101.16%101.16%100.53%65.78%97.83%
Return on Assets (ROA)
-3.69%-3.69%-8.57%-7.68%-5.99%
Return on Equity (ROE)
-10.54%-11.40%-28.35%-21.21%-15.36%
Return on Capital Employed (ROCE)
-6.97%-6.97%-14.63%-17.76%-8.87%
Return on Invested Capital (ROIC)
-6.89%-6.89%-12.97%-17.65%-8.84%
Return on Tangible Assets
-4.58%-4.58%-11.43%-10.78%-9.07%
Earnings Yield
-5.98%-4.76%-19.45%-24.53%-17.00%
Efficiency Ratios
Receivables Turnover
 2.63 2.63 3.24 4.05 3.19
Payables Turnover
 0.36 0.36 0.47 0.43 0.84
Inventory Turnover
 1.07 1.07 1.65 1.32 0.92
Fixed Asset Turnover
 5.17 5.17 5.87 5.62 7.63
Asset Turnover
 0.58 0.58 0.50 0.48 0.45
Working Capital Turnover Ratio
 14.98 17.30 6.03 3.16 1.92
Cash Conversion Cycle
 -536.75 -536.75 -436.67 -477.20 76.12
Days of Sales Outstanding
 138.92 138.92 112.79 90.05 114.37
Days of Inventory Outstanding
 340.82 340.82 221.68 277.32 394.82
Days of Payables Outstanding
 1.02K 1.02K 771.14 844.58 433.07
Operating Cycle
 479.74 479.74 334.47 367.37 509.19
Cash Flow Ratios
Operating Cash Flow Per Share
 0.33 0.33 -0.04 0.43 0.58
Free Cash Flow Per Share
 0.32 0.32 -0.06 0.39 0.44
CapEx Per Share
 <0.01 <0.01 0.01 0.03 0.14
Free Cash Flow to Operating Cash Flow
 0.98 0.98 1.29 0.93 0.75
Dividend Paid and CapEx Coverage Ratio
 50.38 50.38 -3.41 13.45 4.08
Capital Expenditure Coverage Ratio
 50.38 50.38 -3.41 13.45 4.08
Operating Cash Flow Coverage Ratio
 0.48 0.48 -0.03 0.33 0.40
Operating Cash Flow to Sales Ratio
 0.11 0.11 -0.02 0.15 0.20
Free Cash Flow Yield
10.20%8.12%-2.38%22.04%19.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -16.72 -20.99 -5.14 -4.08 -5.88
Price-to-Sales (P/S) Ratio
 1.06 1.34 0.88 0.65 0.78
Price-to-Book (P/B) Ratio
 1.91 2.39 1.46 0.86 0.90
Price-to-Free Cash Flow (P/FCF) Ratio
 9.81 12.31 -42.08 4.54 5.14
Price-to-Operating Cash Flow Ratio
 9.61 12.07 -54.43 4.20 3.88
Price-to-Earnings Growth (PEG) Ratio
 -0.80 0.36 -1.13 -0.26 -0.10
Price-to-Fair Value
 1.91 2.39 1.46 0.86 0.90
Enterprise Value Multiple
 17.18 23.36 196.97 10.34 102.03
Enterprise Value
 46.15M 58.26M 35.93M 25.70M 33.97M
EV to EBITDA
 17.18 23.36 196.97 10.34 102.03
EV to Sales
 1.04 1.31 0.95 0.65 0.81
EV to Free Cash Flow
 9.55 12.05 -45.37 4.56 5.32
EV to Operating Cash Flow
 9.36 11.81 -58.69 4.22 4.02
Tangible Book Value Per Share
 0.64 0.64 0.26 0.40 0.31
Shareholders’ Equity Per Share
 1.66 1.66 1.63 2.07 2.49
Tax and Other Ratios
Effective Tax Rate
 -0.01 -0.01 <0.01 >-0.01 -0.01
Revenue Per Share
 2.98 2.98 2.69 2.77 2.88
Net Income Per Share
 -0.19 -0.19 -0.46 -0.44 -0.38
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.22 1.01 1.10 1.12 1.12
Research & Development to Revenue
 0.13 0.13 0.13 0.15 0.16
SG&A to Revenue
 0.70 0.70 0.74 0.27 0.24
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 0.01
Income Quality
 -1.73 -1.74 0.09 -0.97 -1.50
Currency in USD